Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking Cessation | 30 | 2025 | 137 | 13.890 |
Why?
|
| Anxiety | 26 | 2025 | 173 | 10.240 |
Why?
|
| Cigarette Smoking | 14 | 2025 | 40 | 7.980 |
Why?
|
| Stress Disorders, Post-Traumatic | 12 | 2025 | 63 | 7.470 |
Why?
|
| Adult | 66 | 2025 | 1683 | 7.270 |
Why?
|
| Chronic Pain | 8 | 2024 | 23 | 6.470 |
Why?
|
| Male | 64 | 2025 | 2765 | 6.080 |
Why?
|
| Tobacco Products | 11 | 2024 | 39 | 6.080 |
Why?
|
| Female | 64 | 2025 | 2811 | 6.040 |
Why?
|
| Opioid-Related Disorders | 7 | 2024 | 35 | 5.350 |
Why?
|
| Humans | 74 | 2025 | 5476 | 5.030 |
Why?
|
| Tobacco Use Disorder | 9 | 2024 | 49 | 4.650 |
Why?
|
| Smokers | 14 | 2024 | 49 | 4.520 |
Why?
|
| Electronic Nicotine Delivery Systems | 7 | 2024 | 20 | 4.500 |
Why?
|
| Middle Aged | 36 | 2025 | 1098 | 4.400 |
Why?
|
| Hallucinogens | 5 | 2024 | 8 | 4.130 |
Why?
|
| Cannabis | 5 | 2024 | 20 | 4.050 |
Why?
|
| Smoking | 19 | 2025 | 94 | 3.590 |
Why?
|
| Young Adult | 26 | 2025 | 850 | 3.520 |
Why?
|
| Alcoholism | 8 | 2025 | 43 | 3.290 |
Why?
|
| Anxiety Disorders | 7 | 2024 | 71 | 3.020 |
Why?
|
| United States | 19 | 2024 | 521 | 2.890 |
Why?
|
| Motivation | 7 | 2024 | 70 | 2.680 |
Why?
|
| Prescription Drug Misuse | 3 | 2023 | 9 | 2.410 |
Why?
|
| Adolescent | 17 | 2024 | 806 | 2.330 |
Why?
|
| Emotions | 5 | 2024 | 83 | 2.030 |
Why?
|
| Analgesics, Opioid | 7 | 2024 | 74 | 1.940 |
Why?
|
| Depression | 4 | 2025 | 133 | 1.890 |
Why?
|
| Pain | 7 | 2025 | 40 | 1.890 |
Why?
|
| Alcohol Drinking | 11 | 2025 | 102 | 1.860 |
Why?
|
| Medically Unexplained Symptoms | 3 | 2024 | 11 | 1.830 |
Why?
|
| Health Literacy | 2 | 2024 | 32 | 1.690 |
Why?
|
| Substance-Related Disorders | 2 | 2023 | 52 | 1.540 |
Why?
|
| Stress, Psychological | 4 | 2024 | 88 | 1.350 |
Why?
|
| Racism | 4 | 2024 | 17 | 1.330 |
Why?
|
| Comorbidity | 3 | 2025 | 49 | 1.320 |
Why?
|
| Affect | 5 | 2024 | 30 | 1.290 |
Why?
|
| Pain Measurement | 6 | 2024 | 17 | 1.240 |
Why?
|
| Cross-Sectional Studies | 7 | 2025 | 284 | 1.190 |
Why?
|
| Mental Health | 3 | 2024 | 58 | 1.170 |
Why?
|
| Alcohol-Related Disorders | 4 | 2024 | 17 | 1.140 |
Why?
|
| Mobile Applications | 5 | 2025 | 14 | 1.120 |
Why?
|
| Feasibility Studies | 2 | 2025 | 55 | 1.110 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2024 | 3 | 1.100 |
Why?
|
| Vaping | 2 | 2024 | 11 | 1.090 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 71 | 1.070 |
Why?
|
| Students | 4 | 2024 | 122 | 1.060 |
Why?
|
| Adaptation, Psychological | 6 | 2024 | 44 | 1.060 |
Why?
|
| Self Report | 3 | 2024 | 72 | 0.950 |
Why?
|
| Fatigue | 1 | 2024 | 13 | 0.870 |
Why?
|
| Residence Characteristics | 1 | 2024 | 24 | 0.860 |
Why?
|
| Emigrants and Immigrants | 1 | 2024 | 26 | 0.840 |
Why?
|
| Acculturation | 1 | 2024 | 19 | 0.830 |
Why?
|
| Health Status | 1 | 2023 | 30 | 0.830 |
Why?
|
| Sexual and Gender Minorities | 1 | 2023 | 11 | 0.820 |
Why?
|
| Minority Groups | 1 | 2024 | 39 | 0.820 |
Why?
|
| Low Back Pain | 1 | 2023 | 4 | 0.820 |
Why?
|
| Sleep Wake Disorders | 1 | 2023 | 30 | 0.810 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2022 | 6 | 0.790 |
Why?
|
| Parents | 3 | 2024 | 59 | 0.590 |
Why?
|
| Pilot Projects | 4 | 2025 | 119 | 0.540 |
Why?
|
| Aged | 4 | 2024 | 859 | 0.530 |
Why?
|
| Universities | 3 | 2024 | 80 | 0.480 |
Why?
|
| Nicotine | 3 | 2023 | 38 | 0.440 |
Why?
|
| Marijuana Use | 2 | 2024 | 11 | 0.430 |
Why?
|
| Telemedicine | 2 | 2025 | 37 | 0.420 |
Why?
|
| Pandemics | 2 | 2024 | 82 | 0.400 |
Why?
|
| Tobacco Smoking | 2 | 2023 | 13 | 0.400 |
Why?
|
| Health Behavior | 2 | 2023 | 38 | 0.390 |
Why?
|
| HIV Infections | 2 | 2024 | 115 | 0.350 |
Why?
|
| Behavior Therapy | 3 | 2024 | 28 | 0.310 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 148 | 0.260 |
Why?
|
| Treatment Outcome | 2 | 2025 | 212 | 0.260 |
Why?
|
| Parent-Child Relations | 2 | 2024 | 43 | 0.260 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2024 | 8 | 0.250 |
Why?
|
| Parenting | 2 | 2023 | 48 | 0.240 |
Why?
|
| Quality of Life | 2 | 2023 | 117 | 0.240 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 350 | 0.240 |
Why?
|
| Varenicline | 1 | 2025 | 8 | 0.230 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2024 | 4 | 0.230 |
Why?
|
| Economics, Behavioral | 1 | 2024 | 2 | 0.230 |
Why?
|
| Sex Offenses | 1 | 2024 | 4 | 0.230 |
Why?
|
| Recurrence | 1 | 2025 | 26 | 0.230 |
Why?
|
| Optimism | 1 | 2024 | 4 | 0.220 |
Why?
|
| Qualitative Research | 1 | 2025 | 47 | 0.220 |
Why?
|
| Hope | 1 | 2024 | 7 | 0.220 |
Why?
|
| Acceptance and Commitment Therapy | 1 | 2024 | 1 | 0.220 |
Why?
|
| Alcohol Abstinence | 1 | 2024 | 3 | 0.220 |
Why?
|
| Exercise | 2 | 2024 | 176 | 0.220 |
Why?
|
| Suicide, Attempted | 1 | 2024 | 13 | 0.220 |
Why?
|
| Suicidal Ideation | 1 | 2024 | 20 | 0.220 |
Why?
|
| Smartphone | 1 | 2024 | 15 | 0.220 |
Why?
|
| Ecological Momentary Assessment | 1 | 2024 | 13 | 0.220 |
Why?
|
| Risk Assessment | 1 | 2024 | 49 | 0.220 |
Why?
|
| Feedback, Psychological | 1 | 2024 | 16 | 0.210 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 22 | 0.210 |
Why?
|
| Aggression | 1 | 2023 | 14 | 0.210 |
Why?
|
| Chronic Disease | 1 | 2023 | 29 | 0.210 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 53 | 0.210 |
Why?
|
| Feedback | 1 | 2023 | 32 | 0.210 |
Why?
|
| Self Efficacy | 1 | 2023 | 35 | 0.210 |
Why?
|
| Alcohol Drinking in College | 1 | 2024 | 36 | 0.210 |
Why?
|
| Sexual Behavior | 1 | 2023 | 29 | 0.210 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2023 | 1 | 0.200 |
Why?
|
| Child | 2 | 2023 | 657 | 0.200 |
Why?
|
| Sleep | 1 | 2023 | 62 | 0.200 |
Why?
|
| Brain | 1 | 2023 | 286 | 0.160 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 277 | 0.140 |
Why?
|
| Sex Factors | 2 | 2024 | 81 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2024 | 23 | 0.110 |
Why?
|
| Exercise Therapy | 2 | 2024 | 28 | 0.110 |
Why?
|
| Proof of Concept Study | 1 | 2025 | 7 | 0.060 |
Why?
|
| Bupropion | 1 | 2025 | 8 | 0.060 |
Why?
|
| Schizophrenia | 1 | 2024 | 8 | 0.060 |
Why?
|
| Bipolar Disorder | 1 | 2024 | 11 | 0.050 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 18 | 0.050 |
Why?
|
| Hostility | 1 | 2024 | 3 | 0.050 |
Why?
|
| Anger | 1 | 2024 | 9 | 0.050 |
Why?
|
| Fathers | 1 | 2023 | 9 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2024 | 52 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 1 | 2023 | 2 | 0.050 |
Why?
|
| Catastrophization | 1 | 2023 | 1 | 0.050 |
Why?
|
| Psychometrics | 1 | 2023 | 101 | 0.050 |
Why?
|
| Mothers | 1 | 2023 | 54 | 0.050 |
Why?
|